Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for daclatasvir in Reference Text / Citation (approximate match)

Showing 1 - 10 of 10 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

METHYL N-((1S)-2-METHYL-1-((2S)-2-(5-(4-(4-OXALDEHYDOYLPHENYL)PHENYL)-1H-IMIDAZOL-2-YL)PYRROLIDINE-1-CARBONYL)PROPYL)CARBAMATE

GE6B44J7GP

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2R,3R)-3-HYDROXY-1-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

P7BC3Z5VM7

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

METHYL N-((1S)-1-((2S)-2-(5-(4-(4-((8S)-8-(((2S)-2-AMINO-3-METHYL-BUTANOYL)AMINO)-5-HYDROXY-5,6,7,8-TETRAHYDROIMIDAZO(1,2-A)PYRIDIN-3-YL)PHENYL)PHENYL)-1H-IMIDAZOL-2-YL)PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL)CARBAMATE

H8C9RV6JWH

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (EPIMERIC)

CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-AMINO-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

5V6X9P8JH9

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

4'-(2-((2S)-1-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-CARBOXYLIC ACID

4K8JA2N2S8

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S,3R)-4-HYDROXY-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

SY6HPB2YFS

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

2-(4-(4-(2-((2S)-1-((2S)-2-(METHOXYCARBONYLAMINO)-3-METHYL-BUTANOYL)PYRROLIDIN-2-YL)-1H-IMIDAZOL-5-YL)PHENYL)PHENYL)-2-OXO-ACETIC ACID

3BP5HX5KJU

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

DACLATASVIR

LI2427F9CI

Search for Structure

Status:

US Previously Marketed

Source:

DAKLINZA by BRISTOL-MYERS SQUIBB

(2015)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206843

First approved in 2015

Source:

DAKLINZA by BRISTOL-MYERS SQUIBB

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206843

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Nonstructural protein 5A

Conditions:

Chronic hepatitis C virus genotype 3 infection

Daclatasvir (BMS-790052) is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 3 infection. Daclatasvir prevents RNA replication and virion assembly by binding to NS5A, a nonstructural phosphoprotein encoded by HCV. Binding to the N-terminus of the D1 domain of NS5A prevents its interaction with host cell proteins and membranes required for virion replication complex assembly.

HCV NS5A

2VGG6P316Y

Status:

Other

Class:

STRUCTURALLY DIVERSE

DACLATASVIR DIHYDROCHLORIDE

50ZO25C11D

Search for Structure

Status:

US Previously Marketed

Source:

DAKLINZA by BRISTOL-MYERS SQUIBB

(2015)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206843

First approved in 2015

Source:

DAKLINZA by BRISTOL-MYERS SQUIBB

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206843

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Nonstructural protein 5A

Conditions:

Chronic hepatitis C virus genotype 3 infection

Daclatasvir (BMS-790052) is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 3 infection. Daclatasvir prevents RNA replication and virion assembly by binding to NS5A, a nonstructural phosphoprotein encoded by HCV. Binding to the N-terminus of the D1 domain of NS5A prevents its interaction with host cell proteins and membranes required for virion replication complex assembly.

Structure of METHYL N-((1S)-2-METHYL-1-((2S)-2-(5-(4-(4-OXALDEHYDOYLPHENYL)PHENYL)-1H-IMIDAZOL-2-YL)PYRROLIDINE-1-CARBONYL)PROPYL)CARBAMATE

ABSOLUTE

METHYL N-((1S)-2-METHYL-1-((2S)-2-(5-(4-(4-OXALDEHYDOYLPHENYL)PHENYL)-1H-IMIDAZOL-2-YL)PYRROLIDINE-1-CARBONYL)PROPYL)CARBAMATE

Structure of CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2R,3R)-3-HYDROXY-1-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

ABSOLUTE

CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2R,3R)-3-HYDROXY-1-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

Structure of METHYL N-((1S)-1-((2S)-2-(5-(4-(4-((8S)-8-(((2S)-2-AMINO-3-METHYL-BUTANOYL)AMINO)-5-HYDROXY-5,6,7,8-TETRAHYDROIMIDAZO(1,2-A)PYRIDIN-3-YL)PHENYL)PHENYL)-1H-IMIDAZOL-2-YL)PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL)CARBAMATE

EPIMERIC

METHYL N-((1S)-1-((2S)-2-(5-(4-(4-((8S)-8-(((2S)-2-AMINO-3-METHYL-BUTANOYL)AMINO)-5-HYDROXY-5,6,7,8-TETRAHYDROIMIDAZO(1,2-A)PYRIDIN-3-YL)PHENYL)PHENYL)-1H-IMIDAZOL-2-YL)PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL)CARBAMATE

Structure of CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-AMINO-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

ABSOLUTE

CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2-AMINO-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

Structure of 4'-(2-((2S)-1-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-CARBOXYLIC ACID

ABSOLUTE

4'-(2-((2S)-1-((2S)-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-CARBOXYLIC ACID

Structure of CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S,3R)-4-HYDROXY-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

ABSOLUTE

CARBAMIC ACID, N-((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S,3R)-4-HYDROXY-2-((METHOXYCARBONYL)AMINO)-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)-1H-IMIDAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)-1-PYRROLIDINYL)CARBONYL)-2-METHYLPROPYL)-, METHYL ESTER

Structure of 2-(4-(4-(2-((2S)-1-((2S)-2-(METHOXYCARBONYLAMINO)-3-METHYL-BUTANOYL)PYRROLIDIN-2-YL)-1H-IMIDAZOL-5-YL)PHENYL)PHENYL)-2-OXO-ACETIC ACID

ABSOLUTE

2-(4-(4-(2-((2S)-1-((2S)-2-(METHOXYCARBONYLAMINO)-3-METHYL-BUTANOYL)PYRROLIDIN-2-YL)-1H-IMIDAZOL-5-YL)PHENYL)PHENYL)-2-OXO-ACETIC ACID

Structure of DACLATASVIR

ABSOLUTE

Structurally Diverse

HCV NS5A

Structure of DACLATASVIR DIHYDROCHLORIDE

ABSOLUTE

DACLATASVIR DIHYDROCHLORIDE

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1